title: Symptomatic hypokalemia associated with infliximab in a patient with Crohn's disease.
authors.forename: George
authors.initials: G
authors.lastname: Karamanolis
authors.forename: Charalambos
authors.initials: C
authors.lastname: Tzathas
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Triantafyllou
authors.forename: Zaharias
authors.initials: Z
authors.lastname: Tsiamoulos
authors.forename: Spiros
authors.initials: S
authors.lastname: Ladas
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D000069285:Infliximab; D008297:Male; D010507:Periodicity
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab